Literature DB >> 28555274

Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches.

Adrian Münscher1, Lara Bussmann1, Susanne Sehner2, Simon Knaack1, Alexandra Gliese1, Silke Tribius3, Till Clauditz4, Balazs B Lörincz5,6.   

Abstract

This study is a retrospective analysis of clinico-pathological data to investigate survival rates of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with different modalities in a single academic head and neck cancer center in different time intervals. Altogether, 287 patients with OPSCC were included in this comparison. Patients were analysed during two different treatment periods: Group 1 included patients treated mainly with primary surgery ± adjuvant radio(chemo)therapy between 2002 and 2007, while Group 2 included patients treated with organ/function-preservation protocols if indicated. Main outcome measures were overall survival (OS) and recurrence-free survival (RFS). Between 2002 and 2007, early-stage OPSCC showed a 5-year OS of 75% compared to that of 86% between 2008 and 2013. Locally advanced OPSCC showed a 5-year OS of 66% between 2002 and 2007 compared to that of 74% between 2008 and 2013. RFS in early-stage OPSCC was 48% between 2002 and 2007 in contrast to that of 77% between 2008 and 2013. With locally advanced OPSCC, RFS was 55% between 2002 and 2007 compared to that of 56% between 2008 and 2013. These differences were statistically not significant. The OS and RFS remained generally unchanged over the analysed time period. There was no significant difference in the outcomes with regards to HPV status and to their treatment modality.

Entities:  

Keywords:  Human papilloma virus; Oropharyngeal cancer; Outcomes; Primary chemoradiotherapy; Primary surgery

Mesh:

Year:  2017        PMID: 28555274     DOI: 10.1007/s00405-017-4615-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Transoral robotic surgery and human papillomavirus status: Oncologic results.

Authors:  Marc A Cohen; Gregory S Weinstein; Bert W O'Malley; Michael Feldman; Harry Quon
Journal:  Head Neck       Date:  2010-12-06       Impact factor: 3.147

Review 2.  Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data.

Authors:  Travis D Reeves; Elizabeth G Hill; Kent E Armeson; M Boyd Gillespie
Journal:  Otolaryngol Head Neck Surg       Date:  2011-05       Impact factor: 3.497

3.  Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.

Authors:  Joseph Zenga; Michael Wilson; Douglas R Adkins; Hiram A Gay; Bruce H Haughey; Dorina Kallogjeri; Loren S Michel; Randal C Paniello; Jason T Rich; Wade L Thorstad; Brian Nussenbaum
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-12       Impact factor: 6.223

4.  Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.

Authors:  Genevieve Andrews; Miriam Lango; Roger Cohen; Steven Feigenberg; Barbara Burtness; Ranee Mehra; Sidrah Ahmed; Nicos Nicolaou; John Gaughan; John A Ridge
Journal:  Head Neck       Date:  2010-11-10       Impact factor: 3.147

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation.

Authors:  Adrian Münscher; Susanne Sehner; Jegane Taleh; Silke Tribius; Nicolaus Möckelmann; Arne Böttcher; Amit Gulati; Carsten Dalchow; Till Clauditz; Rainald Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-07       Impact factor: 2.503

Review 7.  Profiling early head and neck cancer.

Authors:  Keith D Hunter; E Ken Parkinson; Paul R Harrison
Journal:  Nat Rev Cancer       Date:  2005-02       Impact factor: 60.716

8.  [Health-related Quality of Life After Oropharyngeal Cancer Treatment].

Authors:  S Volkenstein; J Willers; V Noack; S Dazert; A Minovi
Journal:  Laryngorhinootologie       Date:  2015-06-18       Impact factor: 1.057

9.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

Review 10.  Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

Authors:  Juliana Bonilla-Velez; Edmund A Mroz; Rebecca J Hammon; James W Rocco
Journal:  Otolaryngol Clin North Am       Date:  2013-06-27       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.